Mirae Asset Global Etfs Holdings Ltd. Pds Biotechnology Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,643 shares of PDSB stock, worth $44,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,643Holding current value
$44,954% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
80Shares Held
5.47MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.16 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC360KShares$1.1 Million0.16% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $87.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...